Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or …

COVID's Omicron variant has sparked a slew of concerns across the globe. This review aims
to provide a brief overview of what we know about the Omicron variant right now. The new …

In this study, by characterizing several human monoclonal antibodies (mAbs) isolated from
single B cells of the COVID-19–recovered individuals in India who experienced ancestral …

Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged …

Introduction Patients with cancer have been prioritized for vaccination against severe acute
respiratory syndrome coronavirus 2. Nevertheless, there are limited data regarding the …

Background Patients with cancer were excluded from phase 3 COVID-19 vaccine trials, and
the immunogenicity and side effect profiles of these vaccines in this population is not well …

Patients with cancer are more susceptible to a higher risk of coronavirus infection and its
severe complications than the general population. In addition, these patients were not …

Patients with solid cancer have an increased risk of severe coronavirus disease 2019
(COVID-19) and associated mortality than the general population. This meta-analysis aimed …

Background Being “positive” has been one of the most frustrating words anyone could hear
since the end of 2019. This word had been overused globally due to the high infectious …